ZBH vs. JNJ
Compare and contrast key facts about Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ZBH or JNJ.
Correlation
The correlation between ZBH and JNJ is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ZBH vs. JNJ - Performance Comparison
Key characteristics
ZBH:
-0.80
JNJ:
0.42
ZBH:
-0.91
JNJ:
0.70
ZBH:
0.87
JNJ:
1.10
ZBH:
-0.44
JNJ:
0.47
ZBH:
-1.79
JNJ:
1.28
ZBH:
11.43%
JNJ:
6.35%
ZBH:
25.99%
JNJ:
18.63%
ZBH:
-65.03%
JNJ:
-52.60%
ZBH:
-43.34%
JNJ:
-8.57%
Fundamentals
ZBH:
$20.25B
JNJ:
$372.94B
ZBH:
$4.43
JNJ:
$8.99
ZBH:
23.11
JNJ:
17.24
ZBH:
1.27
JNJ:
1.06
ZBH:
2.66
JNJ:
4.21
ZBH:
1.63
JNJ:
4.81
ZBH:
$7.70B
JNJ:
$89.33B
ZBH:
$5.11B
JNJ:
$61.01B
ZBH:
$1.79B
JNJ:
$34.70B
Returns By Period
In the year-to-date period, ZBH achieves a -9.77% return, which is significantly lower than JNJ's 8.50% return. Over the past 10 years, ZBH has underperformed JNJ with an annualized return of -0.63%, while JNJ has yielded a comparatively higher 7.37% annualized return.
ZBH
-9.77%
-7.47%
-12.11%
-20.60%
-3.52%
-0.63%
JNJ
8.50%
3.77%
0.92%
7.86%
3.80%
7.37%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ZBH vs. JNJ — Risk-Adjusted Performance Rank
ZBH
JNJ
ZBH vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ZBH vs. JNJ - Dividend Comparison
ZBH's dividend yield for the trailing twelve months is around 1.01%, less than JNJ's 3.19% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZBH Zimmer Biomet Holdings, Inc. | 1.01% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% | 0.78% |
JNJ Johnson & Johnson | 3.19% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
ZBH vs. JNJ - Drawdown Comparison
The maximum ZBH drawdown since its inception was -65.03%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for ZBH and JNJ. For additional features, visit the drawdowns tool.
Volatility
ZBH vs. JNJ - Volatility Comparison
Zimmer Biomet Holdings, Inc. (ZBH) has a higher volatility of 14.50% compared to Johnson & Johnson (JNJ) at 5.17%. This indicates that ZBH's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ZBH vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ZBH vs. JNJ - Profitability Comparison
ZBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.21B and revenue of 1.91B. Therefore, the gross margin over that period was 63.3%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
ZBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported an operating income of 338.90M and revenue of 1.91B, resulting in an operating margin of 17.8%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
ZBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a net income of 182.00M and revenue of 1.91B, resulting in a net margin of 9.5%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.